Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi Cherry
How has not communicating improved anything . SP has continuously been dropping since they stopped communicating to a 5 yr low . So I won’t call that a winning strategy either
Same concern
Looks like we are back to square one
I would really like to know the ownership structure of advent and if LP and Les have direct or indirect ownership in it and who are Advents other customers because looks like contract terms are very much on the same lines . I would be pretty upset if there is again related party issues
It’s unbelievable how much some people are detached from reality . They are not able to raise 1M without toxic financing and you think they are some how in works to pull through a 20B dollar buyout
Can you be specific what data will they reveal?
They will still be under embargo from the journal and top line is very unlikely to be available
Yes valid points .
Other explanations of long tail would imply , that they don’t have much confidence in meeting primary or secondary endpoints and hence putting all the eggs in long tail basket at the cost of extreme dilution . I don’t know how else to explain it . Why can’t they say if IA was done or not —- just baffles me ...
Here is my problem with that argument . On one hand people use expletives for nwbo such as “ game changer”, “potential cure”, “ new standard of care” . On the other hand you say that although this is the longest running GBM trial ever , there is still inherent risk of unblinding . If all the expletives were true , data should be self evident by now if unblinded . You can’t have it both ways .
You haven’t missed much
And it is still anyone’s guess when the readout will be . In NWBO’s pet phrase “ stay tuned “... :)
Can you provide a link to phase 2 results
Here is the exact message I get
“Non-equity, bulletin board, OTC, pink sheet, Tick Pilot and other specific securities are not eligible for the price type you have specified.”
It doesn’t give me an option to short even though I have necessary cash in account for margin . I can short any non OTC stock in my account
I have a question for everyone
All the shorts here who claim they keep shorting , I want to know how are they shorting the stock ? From what I understand as a retail investor you can’t short sell an OTC stock . I have accounts in 3 brokerages and I can short NWBO in any of them even if I want to. So my guess is either they work for hedge funds or have no short positions , just pure bashers
Any insight is welcome
So it didn’t come up on the close today ... means no manipulation by your logic
I know
Speed at which we are going , other companies will run and finish the trials and get approvals and we will be still debating if we should wait another year before unblinding .
I don’t think there is any other GBM trial that had more mature data before approval ? Is there any ?
Hi Flip
If both LP and Les had their endpoints in mind , why did they embark on the spring refresh this year , esp when they themselves admit that doing it again this year will be cost prohibitive . Wouldn’t have it made sense to do the refresh somewhere between 7 days from now and November , so that by their own judgement that would have been more probably the final data collection .
Again more answers they give , more questions it generates as what they say and what they do , just don’t make sense sometimes
I know
I have explained the problems about non transparency and lack of news . So according to this successful person , the solution to those problems is to sell your shares and buy again ... makes sense !!
What I would like is some transparency and accountability for the management . Maybe those concepts are alien to you . People who attended the ASM meeting in Jan were given the impression that publication is may be a month or so away , and you go through the posts here and everyone was expecting it in Feb .
Why can’t they officially say if IA was done or not . What law or trial integrity will it jeopardize . One can go in and on . How about Mr Black’s investigation will take 90 days and now we are 900 days away, do you think they should at least post some update even if to say that investigation is ongoing or they have given up on it . You may call it whining , but those are legit questions that management should answer
No there is a problem
Because no one can Time the market . And it does affect the taxes you pay on the gains . I will rather keep the shares that I have owned more than a year to pay long term cap gains if eventually there is a profit to be made. So you see it is not that simple
So seems like UCLA conference will come and go and we will slip back down to .17-.18
Nothing changes in NWBO world
Please point to any previous loan that said that in case of default all they could get is company shares and no other recourse
Hearing anonymous voices is not a good sign . Should seek help
He is doing a Reverse Split
That take is partially correct , only if they are not anticipating major increase in SP . Who is right will be a retrospective thing ... like hindsight is 20/20. Point is that even if under worst case scenario interest is 400 k on 1.2 M loan but makrket cap is up 100% and you can sell shares and pay this loan off , it is relatively non dilutive and good deal
Yes I won’t write home about it , but I am willing to bet this accountant guy to come back in August and debate whether it was a good deal or not
I bet he won’t be seen anywhere
Why don’t you go back and read the filing and probably after that look in a reputable dictionary the meaning of per annum
It clearly says “6% per annum”
The terms are much better than 10% interest and 100% warrant coverage
I believe 6% interest is annualized
Yes it is interesting , if he was a shark lender he would look for better opportunities than 6% and no warrants . For 4 months of interest , he will probably spend half of it in legal fees and other closing and recording fees etc . Only carrot he has is if he can convert the loan into shares at the SP of closing the loan .
Just thinking out loud
And why on earth can’t NWBO say that they haven’t conducted IA? What legal or ethical conduct will it go against ....
I agree. They are banking on selling shares at higher price in next couple of months and pay off the loan , that’s why short term loan . There are only two things that can make that happen , publication( only if data is unequivocally positive ) or top line . Announcing combo trials wont move SP more than 5 cents I think . So yet again let’s “ stay tuned “
Hi Flip
8k from today seems strange as they are taking loan for 6 months from some LLC - maturing in Aug. so if they are not planning to unblind soon, why not take loan for a year to get to next years spring refresh .
“Staying tuned”
It’s a promissory note of approx 1.3M to some Adars Bay LLC at 6% maturing in Aug 18
Hi Bear
My tuner is overheated by “Staying tuned” for year and a half . I may have to change my tuner soon :)
I know , but my skepticism now says that only reason they are waiting for blinded publication is so that can sell more shares at higher price as they seem to be in no hurry to do the data lock and apply for any kind of approval .
Exactly
And therefore no price appreciation at all as they keep kicking the can down the road . They have given no indication of some finiteness of the process during this meeting either . As I said before market won’t get interested till it’s clear that end is in sight .
So who is willing to bet that nothing will happen before UCLA conference either and the conference will come and go just like any other non event and we will find out that postponement of the conference had nothing to with DCVax trial
Just venting ...:)
I also appreciate everyone’s effort to go to the meeting and transcribe notes and answer questions of the posters here .
But I still am disappointed , as all the statements made there pretty much can be summarized as “stay tuned “ still. No clear indication that this is last refresh , and plan for datalock and unblinding and delineate 2-3 paths for approval they will pursue . Even this late everything stays very non specific and non committal . And hence apathy of the market and SP still below the last preferred shares . They got to give the impression to the market that they are organized and give specific plan/s . Market just doesn’t have any faith in them delivering and hence no appreciation in SP .
And for any CPXX example , one can find few dozen examples that didn’t end well , before some one posts it
Any long from more than 2-3 yrs ago , if finds himself waiting for ASCO 2019 for an update and unblinding will never recover any money . He would have been better if donating money to any of the respected cancer charities and writing it off
And then what?
And I have no idea why my original message you responded to was deleted by moderators , except for some autocorrect issues. I type all my messages from my iPhone , so I am sure there are some grammatical and brevity issues
Exavtly
I can’t think of any reason , if they are so confident about treatment to keep going on for another 6-12 months
As I have said before , this is a diseas with median survival counter in months , if you can’t show efficacy in 10.5 yrs , you sure won’t be able to in 11 yrs either . And even if you can , thorn it’s not a groundbreaking treatment or a cure everybody is touting about
Flip
If she sees know problem with PFS , then what’s the problem with unblinding ??